# Anna Sureda

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/anna-sureda/

## Facts

| Field | Value |
| --- | --- |
| Citations | 34,658 |
| Field | Lymphoma Diagnosis and Treatment |
| h-index | 93 |
| i10-index | 445 |
| Last Known Institution | Institut d'Investigació Biomédica de Bellvitge |
| OpenAlex ID | https://openalex.org/A5077430940 |
| ORCID iD | https://orcid.org/0000-0002-1238-6970 |
| Works | 1,102 |

## Researcher papers

- [Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma](https://scholariq.org/papers/daratumumab-bortezomib-lenalidomide-and-dexamethasone-for-multiple-myeloma/)
- [Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations](https://scholariq.org/papers/immune-effector-cell-associated-hematotoxicity-eha-ebmt-consensus-grading-and/)

## Researcher topics

- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Hematopoietic Stem Cell Transplantation](https://scholariq.org/topics/hematopoietic-stem-cell-transplantation/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Researcher university

- [Institut d'Investigació Biomédica de Bellvitge](https://scholariq.org/institutions/institut-d-investigacio-biomedica-de-bellvitge/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.